OPKO Health was incorporated in Delaware in 1991 as Cytoclonal Pharmaceutics, Inc.
The company expects to report financial results for the fourth quarter 2017 and the year 2017 in February, 2018. No specific day yet selected.
OPKO Health common stock is traded on the New York Stock Exchange under the symbol “OPK.”
The company’s most recent investor presentation is available in the “Investors” section on the company’s website. It can also be accessed at the “Events” page of the “Investors” section on the company’s website.
The fiscal year ends on December 31.
OPKO Health does not offer a direct stock purchase plan. Shares of the company can be purchased through a brokerage company.
OPKO Health, Inc. has never declared or paid cash dividends. The company intends to retain any future earnings for the operation and expansion of its business and does not anticipate paying any cash dividends in the foreseeable future.
The date and location will be published in the company’s proxy statement, which can be found on the “SEC Filings” section in the “Investors” section on the company’s website.
OPKO Health Corporate Headquarters
4400 Biscayne Blvd.
Miami, FL 33137
Tel: (305) 575-4100
American Stock Transfer & Trust Company, LLC,
6201 15th Ave.
Brooklyn, NY 11209
Toll-free at (877) 248-6417 or
To replace lost stock certificates, please contact OPKO Health’s transfer agent
To change your address, please contact OPKO Health’s transfer agent.
For questions related to the exchange of BRLI shares for OPK shares, please contact OPKO Health’s transfer agent.